BfArM — authorised 14 January 2015
- Marketing authorisation holder: NOVARTIS EUROPHARM LIMITED
- Status: approved
BfArM authorised Cosentyx on 14 January 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. BfArM authorised it on 14 January 2015.
NOVARTIS EUROPHARM LIMITED holds the German marketing authorisation.